Additionally, RES was found to decrease the expression of IL-6, IL-8, MCP-1, and VEGF genes, as well as protein secretion, and counteract the activation of the Wnt/β-catenin signaling pathway induced by gastric cancer-derived mesenchymal stem cells in gastric cancer cells with less β-catenin expression. The gene discussed is CCL2; the disease is gastric cancer.